Ganluyin ameliorates DSS-induced ulcerative colitis by inhibiting the enteric-origin LPS/TLR4/NF-κB pathway.
Xiong T, Zheng X, Zhang K, Wu H, Dong Y, Zhou F, Cheng B, Li L, Xu W, Su J, Huang J, Jiang Z, Li B, Zhang B, Lv G, Chen S.
Xiong T, et al. Among authors: huang j.
J Ethnopharmacol. 2022 May 10;289:115001. doi: 10.1016/j.jep.2022.115001. Epub 2022 Jan 24.
J Ethnopharmacol. 2022.
PMID: 35085745